Richard J. Travers

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications”.

VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications

Current Oncology Reports(2022)10.1007/s11912-022-01224-0

N/A

0DataRank · unranked

77 citations

Richard J. Travers, Vicky K. Yang, Cheryl A. London, Iris Z. Jaffe, Nicholas D. Camarda

Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors

PLoS ONE(2023)10.1371/journal.pone.0294438

N/A

0DataRank · unranked

17 citations

Richard J. Travers, Alanna Farrell, Qing Lu, Jennifer Bays, Alec Stepanian +3 more

Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors

Clinical Science(2024)10.1042/cs20240537

N/A

0DataRank · unranked

7 citations

Qing Lu, Dawn M. Meola, Joshua J. Man, Zeyuan Song, Richard J. Travers +17 more

Antipolyphosphate monoclonal antibodies derived from autoimmune mice

Research and Practice in Thrombosis and Haemostasis(2024)10.1016/j.rpth.2024.102550

N/A

0DataRank · unranked

3 citations

Stephanie A. Smith, A. J. Scott, Yuqi Wang, Richard J. Travers, Rachel Hemp +3 more

Distinct endothelial cell toxicities of Abl tyrosine kinase inhibitors lead to arterial thrombosis

Blood Vessels Thrombosis & Hemostasis(2025)10.1016/j.bvth.2025.100127

N/A

0DataRank · unranked

2 citations

Alec Stepanian, Sebastiana Redford, Gregory Martin, Nicole L. Svedberg, Kun Xu +5 more

Permissive Cardiotoxicity and Determination of Anthracycline Risk With Previous Anthracycline Exposure

JACC Case Reports(2025)10.1016/j.jaccas.2025.104028

N/A

0DataRank · unranked

0 citations

Nicholas D. Camarda, Iris Z. Jaffe, Raphael A Lizcano, Jenica Upshaw, Richard J. Travers